Original language | English |
---|---|
Pages (from-to) | 2387-2391 |
Number of pages | 5 |
Journal | Blood Advances |
Volume | 4 |
Issue number | 11 |
DOIs | |
State | Published - Jun 9 2020 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient. / Oza, Aabha; Rettig, Michael P.; Powell, Phil; O'Brien, Kathryn; Clifford, David B.; Ritchey, Julie; Gehrs, Leah; Hollaway, Julia; Major, Eugene; Fehniger, Todd A.; Miller, Christopher A.; Soon-Shiong, Patrick; Rock, Amy; DiPersio, John F.
In: Blood Advances, Vol. 4, No. 11, 09.06.2020, p. 2387-2391.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient
AU - Oza, Aabha
AU - Rettig, Michael P.
AU - Powell, Phil
AU - O'Brien, Kathryn
AU - Clifford, David B.
AU - Ritchey, Julie
AU - Gehrs, Leah
AU - Hollaway, Julia
AU - Major, Eugene
AU - Fehniger, Todd A.
AU - Miller, Christopher A.
AU - Soon-Shiong, Patrick
AU - Rock, Amy
AU - DiPersio, John F.
N1 - Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant (P30 CA091842).
PY - 2020/6/9
Y1 - 2020/6/9
UR - http://www.scopus.com/inward/record.url?scp=85088408636&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2019000664
DO - 10.1182/bloodadvances.2019000664
M3 - Article
C2 - 32484854
AN - SCOPUS:85088408636
VL - 4
SP - 2387
EP - 2391
JO - Blood advances
JF - Blood advances
SN - 2473-9529
IS - 11
ER -